title: [Preliminary research of hepatocarcinoma stem cell markers].
abstract: OBJECTIVE
  To study human hepatocarcinoma stem cell markers.
  
  
  METHODS
  Tumor tissue samples were obtained from 8 patients with hepatic cellular cancer undergoing surgical tumor resection and the tumor cells were cultured with primary tissue culture in vitro. The cell subpopulations with each marker were isolated from the tumor cells by immunopanning using oval cell markers (CD34, c-kit, Thy-1, CK7, CK19, CK14). The cells of each phenotype were injected into nude mice to measure their ability of tumor formation and the tumor mass was weighed one month after implantation. The tumorigenic subpopulations of the cells were injected into the nude mice again in 1/4 or 1/10 of their original densities to further analyze their ability of tumor formation.
  
  
  RESULTS
  Among all the cell subpopulations, those positive for CD34, c-kit and CK7, respectively, showed marked difference from the negative cells in their ability of proliferation and tumor formation. The CD34(-), c-kit(+) and CK7(+) subpopulations of the cells exhibited strong capacity of tumor formation even in only 1/4 or 1/10 of their original density.
  
  
  CONCLUSIONS
  There are heterogeneous subpopulations within human hepatocarcinoma with observable difference in tumor formation ability. The strong tumor formation ability of CD34(-), c-kit(+) and CK7(+) subpopulation of the cells suggests that CD34(-), c-kit(+) and CK7(+) represent part of the surface markers of hepatocarcinoma stem cells.
authors.affiliation: Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China. yanzheng63325@hotmail.com
authors.forename: Zheng
authors.initials: Z
authors.lastname: Yan
authors.forename: Chi-hua
authors.initials: CH
authors.lastname: Fang
authors.forename: Peng
authors.initials: P
authors.lastname: Gao
mesh_terms: D018952:Antigens, CD34 / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D053552:Keratin-7 / Q000032:analysis; D008113:Liver Neoplasms / Q000378:metabolism / Q000473:pathology*; D014411:Neoplastic Stem Cells / Q000378:metabolism*; D019009:Proto-Oncogene Proteins c-kit / Q000032:analysis; D014407:Tumor Cells, Cultured
chemical_list: D018952:Antigens, CD34; D014408:Biomarkers, Tumor; D053552:Keratin-7; D019009:Proto-Oncogene Proteins c-kit